OWLT
Owlet, Inc.
$5.50
-0.13 (-2.31%)
At close · Jul 8
Market Cap
$172.56M
Shares
29,001,168
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.50
Open$5.58
Day$5.27–5.66
52W$4.19–16.94
Avg vol 30d259K
Short int475K · 1.6% float · 1.9d
Short vol46%
Last earningsMay 7, 2026
DataNov 2020–Jul 2026
Filing10-Q · May 11
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−39%
below
Price vs 50-day avg
+4%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
10%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+15%
trailing
6-month return
−61%
trailing
YTD return
−66%
this year
Relative strength
−69%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
2 of 67 funds reported for Jun 30 · net +72.5K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.64% of float · ▼ -19.9% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
67 holders — mid 3-yr range
Squeeze score
42
elevated · 0–100
Fundamentals
Revenue growth
+35%
Y/Y
Gross margin
51%
expanding
EPS growth
+65%
Y/Y
Free cash flow
$-11.1M
Balance sheet
$29.5M
net cash
Quant / Vol
risk profile
Volatility
87%
annualized · 1-yr
Max drawdown
−73%
past year
ATR
7.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Jul 30, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed May 7, 2026
Total revenue
· full year 2026
Maintained
$118M – $122M
prior FY $105.71M
midpoint +13.5% Y/Y
Gross margins
· full year 2026
Initiated
50% – 52%
Adjusted EBITDA
· full year 2026
Non-GAAP
Initiated
$7M – $9M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−39%
Bearish
Price vs 50-day avg
+4%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
10%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
2 of 67 funds reported for Jun 30 · net +72.5K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.64% of float · ▼ -19.9% MoM · 1.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
67 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $4
Now $6 · 10%
52-wk high $17
vs 200-day avg -39%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Subscription gross margin | 67.4% | Q1 2026 | — |
| Subscription Revenue | $2.7M | Q1 2026 | — |
| new Owlet device purchasers annually | 0.5M | annually call | — |
| paying subscribers | 110,000 | Full Year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OWLT
this stock
Owlet, Inc.
|
$172.56M | -66.0% | +35.4% | — | 1.6% |
|
ABT
Abbott Laboratories
|
$164.43B | -23.6% | +5.7% | 26.4 | 1.3% |
|
SYK
Stryker Corp
|
$125.40B | -6.8% | +11.2% | 37.9 | 1.6% |
|
MDT
Medtronic plc
|
$105.46B | -13.9% | +8.4% | 22.1 | 1.4% |
|
BSX
Boston Scientific Corp
|
$66.87B | -53.0% | +5.5% | 18.8 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OWLT | -4.2% | +14.8% | -61.3% | -4.2% | -66.0% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -4.0% | +14.0% | -68.7% | -4.0% | -75.3% |